放疗对行化疗和手术的直肠癌患者的效果分析:一项基于SEER数据库的回顾性研究
|
王安君, 刘宁宁
|
Efficacy of radiotherapy in patients with rectal cancer undergoing chemotherapy and surgery: a retrospective study based on the SEER database
|
WANG Anjun, LIU Ningning
|
|
表6 S组和S+RT组直肠癌患者OS和CSS的单因素和多因素Cox回归分析
|
Tab 6 Univariate and multivariate Cox regression analysis of OS and CSS of rectal cancer patients between the S group and the S+RT group
|
|
Factor | OS | CSS |
---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis |
---|
HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value |
---|
Group | | | | | | | | | S | Reference | | | | Reference | | | | S+RT | 1.12 (0.96‒1.30) | 0.150 | | | 1.13 (0.95‒1.34) | 0.166 | | | Age | | | | | | | | | <50 years | Reference | | Reference | | Reference | | Reference | | ≥50 years | 1.55 (1.25‒1.92) | 0.000 | 1.82 (1.46‒2.26) | 0.000 | 1.30 (1.04‒1.64) | 0.024 | 1.81 (1.45‒2.24) | 0.000 | Gender | | | | | | | | | Male | Reference | | | | Reference | | | | Female | 0.98 (0.84‒1.14) | 0.750 | | | 1.00 (0.84‒1.19) | 0.992 | | | Race | | | | | | | | | White | Reference | | Reference | | Reference | | | | Black | 1.30 (1.01‒1.67) | 0.045 | 1.35 (1.04‒1.75) | 0.024 | 1.25 (0.94‒1.67) | 0.125 | | | Others | 0.81 (0.65‒1.01) | 0.065 | 0.99 (0.79‒1.24) | 0.914 | 0.81 (0.63‒1.04) | 0.101 | | | Marital status | | | | | | | | | Married | Reference | | Reference | | Reference | | Reference | | Others | 1.43 (1.23‒1.67) | 0.000 | 1.35 (1.16‒1.58) | 0.000 | 1.42 (1.19‒1.68) | 0.000 | 1.39 (1.19‒1.62) | 0.000 | Tumor histology | | | | | | | | | Adenocarcinoma | Reference | | | | Reference | | | | Others | 1.07 (0.90‒1.27) | 0.426 | | | 1.14 (0.94‒1.38) | 0.185 | | | Tumor size | | | | | | | | | ≤30 mm | Reference | | Reference | | Reference | | Reference | | >30‒50 mm | 1.78 (1.44‒2.21) | 0.000 | 1.64 (1.32‒2.05) | 0.000 | 1.90 (1.48‒2.43) | 0.000 | 1.64 (1.32‒2.05) | 0.000 | >50 mm | 2.15 (1.72‒2.70) | 0.000 | 2.01 (1.59‒2.54) | 0.000 | 2.41 (1.86‒3.12) | 0.000 | 2.02 (1.60‒2.56) | 0.000 | Histologic grade | | | | | | | | | Well differentiated | Reference | | Reference | | Reference | | Reference | | Moderately differentiated | 0.94 (0.62‒1.44) | 0.790 | 0.88 (0.58‒1.34) | 0.549 | 1.08 (0.65‒1.78) | 0.771 | 0.89 (0.58‒1.35) | 0.574 | Poorly differentiated/ undifferentiated | 1.58 (1.02‒2.45) | 0.041 | 1.38 (0.89‒2.16) | 0.150 | 1.86 (1.11‒3.13) | 0.019 | 1.40 (0.90‒2.17) | 0.139 | TNM stage | | | | | | | | | Ⅰ | Reference | | Reference | | Reference | | Reference | | Ⅱ | 1.11 (0.72‒1.70) | 0.635 | 0.78 (0.50‒1.22) | 0.280 | 1.48 (0.86‒2.55) | 0.160 | 0.76 (0.49‒1.19) | 0.232 | Ⅲ | 1.45 (0.98‒2.12) | 0.060 | 1.10 (0.74‒1.64) | 0.634 | 1.88 (1.14‒3.12) | 0.014 | 1.07 (0.72‒1.58) | 0.753 | Ⅳ | 4.67 (3.13‒6.98) | 0.000 | 3.54 (2.33‒5.38) | 0.000 | 7.30 (4.36‒12.23) | 0.000 | 3.39 (2.24‒5.15) | 0.000 | Regional nodes examined | | | | | | | | | <12 | Reference | | | | Reference | | | | ≥12 | 0.89 (0.76‒1.04) | 0.137 | | | 0.99 (0.83‒1.18) | 0.894 | | |
|
|
|